Granahan Investment Management LLC Has $14.08 Million Stock Position in OrthoPediatrics Corp. $KIDS

Granahan Investment Management LLC reduced its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 21.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 759,951 shares of the company’s stock after selling 206,877 shares during the quarter. Granahan Investment Management LLC owned 3.03% of OrthoPediatrics worth $14,082,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Aquatic Capital Management LLC lifted its stake in shares of OrthoPediatrics by 149.7% in the 3rd quarter. Aquatic Capital Management LLC now owns 17,729 shares of the company’s stock valued at $329,000 after acquiring an additional 10,629 shares during the last quarter. Deerfield Management Company L.P. increased its position in OrthoPediatrics by 1,153.4% in the 3rd quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock valued at $3,597,000 after acquiring an additional 178,623 shares during the period. Caption Management LLC bought a new position in shares of OrthoPediatrics during the third quarter valued at $54,000. Prosight Management LP raised its stake in shares of OrthoPediatrics by 319.2% during the third quarter. Prosight Management LP now owns 308,707 shares of the company’s stock valued at $5,720,000 after acquiring an additional 235,060 shares during the last quarter. Finally, Marshall Wace LLP lifted its holdings in shares of OrthoPediatrics by 6.0% during the third quarter. Marshall Wace LLP now owns 444,320 shares of the company’s stock worth $8,233,000 after purchasing an additional 25,191 shares during the period. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Stock Performance

Shares of KIDS opened at $17.31 on Monday. The company has a debt-to-equity ratio of 0.28, a current ratio of 5.55 and a quick ratio of 2.65. OrthoPediatrics Corp. has a one year low of $15.28 and a one year high of $26.40. The stock has a 50-day moving average of $17.76 and a 200-day moving average of $18.00. The company has a market cap of $437.60 million, a PE ratio of -10.24 and a beta of 1.07.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Thursday, February 26th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.11. The firm had revenue of $61.61 million during the quarter, compared to the consensus estimate of $61.27 million. OrthoPediatrics had a negative return on equity of 6.70% and a negative net margin of 16.77%. On average, equities research analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on KIDS. Wall Street Zen raised shares of OrthoPediatrics from a “sell” rating to a “hold” rating in a research note on Saturday, March 7th. Canaccord Genuity Group initiated coverage on OrthoPediatrics in a report on Wednesday, December 10th. They set a “buy” rating and a $24.00 target price on the stock. Needham & Company LLC upped their price target on OrthoPediatrics from $26.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Weiss Ratings reissued a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Thursday, January 22nd. Finally, TD Cowen upgraded OrthoPediatrics to a “strong-buy” rating in a research report on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.67.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.